AstroNova - Public Comps and Valuation Multiples

AstroNova Overview

About AstroNova

AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.

Founded

1969

HQ

Employees

365

Website

astronovainc.com

Sectors

Electronic Equipment
Peripherals
DeepTech

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$107M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

AstroNova Financials

AstroNova has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, AstroNova achieved revenue of $148M and an EBITDA of $13.0M.

AstroNova expects next 12-month revenue of XXX and NTM EBITDA of XXX

See AstroNova valuation multiples based on analyst estimates

AstroNova P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$143M	$148M	XXX	XXX	XXX
Gross Profit	$43.7M	$48.2M	XXX	XXX	XXX
Gross Margin	31%	33%	XXX	XXX	XXX
EBITDA	$9.0M	$13.0M	XXX	XXX	XXX
EBITDA Margin	6%	9%	XXX	XXX	XXX
Net Profit	$6.4M	$2.7M	XXX	XXX	XXX
Net Margin	5%	2%	XXX	XXX	XXX
Net Debt	$3.9M	$26.1M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

AstroNova Stock Performance

As of April 15, 2025, AstroNova's stock price is $8.

AstroNova has current market cap of $61.0M, and EV of $107M.

See AstroNova trading valuation data

AstroNova Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$107M	$61.0M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

AstroNova Valuation Multiples

As of April 15, 2025, AstroNova has market cap of $61.0M and EV of $107M.

AstroNova's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate AstroNova's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for AstroNova and 10K+ public comps

AstroNova Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$107M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	XXX	XXX
P/E	n/a	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	n/a	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get AstroNova Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

AstroNova Valuation Multiples

AstroNova's NTM/LTM revenue growth is n/a

AstroNova's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, AstroNova's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate AstroNova's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for AstroNova and other 10K+ public comps

AstroNova Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	4%	XXX	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	XXX	XXX	XXX
EBITDA Growth	45%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	$0.4M	XXX	XXX	XXX	XXX
Opex per Employee	$0.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	16%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	8%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	5%	XXX	XXX	XXX	XXX
Opex to Revenue	29%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry